Insider Transactions in Q2 2021 at Optimize Rx Corp (OPRX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Gus D Halas Director |
BUY
Grant, award, or other acquisition
|
Direct |
407
+0.62%
|
-
|
|
Jun 30
2021
|
James Paul Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
407
+1.23%
|
-
|
|
Jun 30
2021
|
Patrick D Spangler Director |
BUY
Grant, award, or other acquisition
|
Direct |
407
+1.79%
|
-
|
|
Jun 30
2021
|
Ellen O'Connor Vos Director |
BUY
Grant, award, or other acquisition
|
Direct |
407
+1.22%
|
-
|
|
Jun 30
2021
|
Gregory D Wasson Director |
BUY
Grant, award, or other acquisition
|
Direct |
407
+2.22%
|
-
|
|
Jun 28
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,421
-3.97%
|
$215,523
$63.0 P/Share
|
|
Jun 24
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-4.43%
|
$240,000
$60.0 P/Share
|
|
Jun 17
2021
|
Stephen L Silvestro Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
13,242
-100.0%
|
$701,826
$53.44 P/Share
|
|
Jun 17
2021
|
Stephen L Silvestro Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,242
+50.0%
|
$92,694
$7.51 P/Share
|
|
Jun 07
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,500
+13.85%
|
$29,000
$2.46 P/Share
|
|
Jun 07
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
14,500
-16.07%
|
$754,000
$52.62 P/Share
|
|
Jun 04
2021
|
Miriam J Paramore PRESIDENT AND CSO |
BUY
Open market or private sale
|
Direct |
13,333
+64.27%
|
$666,650
$50.85 P/Share
|
|
Jun 04
2021
|
Miriam J Paramore PRESIDENT AND CSO |
SELL
Exercise of conversion of derivative security
|
Direct |
13,333
-39.12%
|
$39,999
$3.15 P/Share
|
|
Jun 04
2021
|
Miriam J Paramore PRESIDENT AND CSO |
SELL
Open market or private sale
|
Direct |
1,667
-18.36%
|
$85,017
$51.3 P/Share
|
|
May 18
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,500
+13.85%
|
$29,000
$2.46 P/Share
|
|
May 18
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
14,500
-16.07%
|
$652,500
$45.85 P/Share
|
|
May 17
2021
|
Stephen L Silvestro Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,242
+50.0%
|
$92,694
$7.51 P/Share
|
|
May 17
2021
|
Stephen L Silvestro Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
13,242
-100.0%
|
$556,164
$42.72 P/Share
|
|
May 17
2021
|
Miriam J Paramore PRESIDENT AND CSO |
SELL
Open market or private sale
|
Direct |
15,000
-62.29%
|
$630,000
$42.95 P/Share
|